Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$185.77 USD
+3.62 (1.99%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $184.71 -1.06 (-0.57%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/12/25 |
---|---|
Current Quarter | 2.53 |
EPS Last Quarter | 2.59 |
Last EPS Surprise | 6.58% |
ABR | 2.65 |
Earnings ESP
|
-2.18% |
---|---|
Current Year | 10.18 |
Next Year | 10.30 |
EPS (TTM) | 10.12 |
P/E (F1) | 18.24 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 977.39M | 979.51M | 4.02B | 4.08B |
# of Estimates | 6 | 5 | 6 | 6 |
High Estimate | 990.59M | 985.80M | 4.04B | 4.11B |
Low Estimate | 965.50M | 967.40M | 4.01B | 4.04B |
Year ago Sales | 1.01B | 1.01B | 4.13B | 4.02B |
Year over Year Growth Est. | -3.56% | -3.17% | -2.53% | 1.26% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.53 | 2.37 | 10.18 | 10.30 |
# of Estimates | 8 | 5 | 9 | 9 |
Most Recent Consensus | 2.47 | 2.42 | 10.13 | 10.07 |
High Estimate | 2.62 | 2.42 | 10.28 | 10.80 |
Low Estimate | 2.45 | 2.32 | 10.10 | 9.94 |
Year ago EPS | 2.46 | 2.27 | 10.67 | 10.18 |
Year over Year Growth Est. | 2.85% | 4.41% | -4.59% | 1.15% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 2 | 1 |
Up Last 60 Days | 3 | 0 | 9 | 2 |
Down Last 7 Days | 0 | 2 | 0 | 1 |
Down Last 30 Days | 1 | 3 | 0 | 3 |
Down Last 60 Days | 2 | 5 | 0 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.53 | 2.37 | 10.18 | 10.30 |
7 Days Ago | 2.53 | 2.45 | 10.18 | 10.32 |
30 Days Ago | 2.53 | 2.45 | 10.14 | 10.39 |
60 Days Ago | 2.52 | 2.45 | 10.01 | 10.54 |
90 Days Ago | 2.53 | 2.50 | 10.01 | 10.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.47 | 2.35 | 10.16 | 10.14 |
Zacks Consensus Estimate | 2.53 | 2.37 | 10.18 | 10.30 |
Earnings ESP | -2.18% | -0.63% | -0.28% | -1.58% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.59 | 2.80 | 2.27 | 2.46 | NA |
Estimate | 2.43 | 2.39 | 2.05 | 2.39 | NA |
Difference | 0.16 | 0.41 | 0.22 | 0.07 | 0.22 |
Surprise | 6.58% | 17.15% | 10.73% | 2.93% | 9.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more